PhXa 85,
PhXa-85,
PhXa85,
Latanoprost acid,
Phxa 85,
41639-83-2,
UNII-EJ85341990,
CHEBI:63925,
Latanprost Free Acid,
Phxa-85,
EJ85341990,
(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoic acid,
13,14-dihydro-17-phenyl-18,19,20-trinor-PGF2alpha,
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid,
Latanoprost (free acid),
PHXA85,
latanoprost-free acid,
AC1O5VOE,
CHEMBL1050,
latanoprost (free acid form),
GTPL1960,
SCHEMBL1313159,
DTXSID6040531,
HNPFPERDNWXAGS-NFVOFSAMSA-N,
HMS3648J04,
Latanoprost acid, >=98% (HPLC),
MFCD08056084,
ZINC13589951,
NCGC00165820-01,
SC-44791,
Z6154,
639L832,
SR-01000946512,
SR-01000946512-1,
13,14-Dihydro-17-phenyl-18,19,20-trinor-PGF2|A,
Latanoprost Related Compound E, United States Pharmacopeia (USP) Reference Standard,
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid,
(5Z,9alpha,11alpha,15R)-9,11,15-Trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oic acid,
(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)-cyclopentyl)hept-5-enoic acid,
5-Heptenoic acid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,(5Z)-,
Latanoprostacid,
Latanprost acid,
latanoprost free acid,
C23H34O5,
CID6441636,
CS-T-57190,